Clinical Trials · NCT02302976
GLP-1 Agonism for Blocking Cocaine Euphoria and Self-Administration
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Yale University
- Enrollment
- 13
- Start date
- Nov 2014
- Locations
- 1 site, United States
- Primary endpoint
- Mean cocaine inter-infusion interval